![Simon Green](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Green
Directeur/Bestuurslid bij
CLOVER CORPORATION LIMITED
Vermogen: 36 617 $ op 31-05-2026
Profiel
Simon P.
Green is the founder of Immunosis Pty Ltd. since 2015, holding the title of Chief Executive Officer.
Current jobs include Independent Non-Executive Director at Syntara Ltd. since 2022, Independent Non-Executive Director at Clover Corp.
Ltd. since 2020, and Venture Partner at Bioscience Managers Pty Ltd. since 2020.
Former jobs include Independent Non-Executive Director at Acrux Ltd. from 2016 to 2019 and Senior Vice President-Research & Development at CSL Behring GmbH from 2008 to 2012.
Education includes a doctorate from the University of Melbourne conferred in 1992 and an undergraduate degree from Monash University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-07-2025 | 56.234 ( 0,03% ) | 36 617 $ | 31-05-2026 |
Actieve functies van Simon Green
| Bedrijven | Functie | Begin |
|---|---|---|
| CLOVER CORPORATION LIMITED | Directeur/Bestuurslid | 20-10-2020 |
| SYNTARA LIMITED | Directeur/Bestuurslid | 16-12-2022 |
Immunosis Pty Ltd.
 Immunosis Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Algemeen Directeur | 01-11-2015 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity Investor | 01-05-2020 |
Eerdere bekende functies van Simon Green
| Bedrijven | Functie | Einde |
|---|---|---|
| ACRUX LIMITED | Directeur/Bestuurslid | 01-01-2019 |
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
Opleiding van Simon Green
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
69
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Syntara Ltd.
 Syntara Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceutical products for respiratory disorders | Health Technology |
Clover Corp. Ltd.
 Clover Corp. Ltd. Pharmaceuticals: OtherHealth Technology Produces and sells tuna oil and encapsulated products | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrux Ltd.
 Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Immunosis Pty Ltd.
Immunosis Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
